Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
3
×
detroit blog main
detroit top stories
3
×
national blog main
national top stories
new york blog main
raleigh-durham blog main
san francisco blog main
wisconsin blog main
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
fda
indiana blog main
indiana top stories
life sciences
national
new york top stories
precision medicine
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin top stories
arboretum ventures
arena pharmaceuticals
aurora health care
baird capital
blueprint medicines
cardiovascular disease
colorectal cancer
companion diagnostic
dan rhodes
What
medicine
3
×
cancer
drug
fda
ann
approved
arbor
based
closed
company
deeper
dna
eisai
fingerprint
flags
genetic
going
higher
huge
incidence
lead
leaders
lorcaserin
loss
market
marketing
matter
merck
million
nd
new
oks
oncology
oncology’s
patients
pfizer
post
precision
pulls
risks
Language
unset
Current search:
cancer
×
medicine
×
" detroit top stories "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Pfizer, Merck Lead Strata Oncology’s $26M Series B Round